When all Chronic Limb-Threatening Ischemia (CLTI) treatment options have been exhausted, the LimFlow Transcatheter Arterialization of Deep Veins System is designed to restore blood flow to the ischemic foot.
FDA approves LimFlow System for treatment of Chronic
Limb-Threatening Ischemia (CLTI)
“This exciting new therapy has the potential to restore blood flow to the ischemic foot, which may help patients heal their wounds and keep their feet.”
Dan Clair, MD, Vascular Surgeon
Professor and Chair, Department of Vascular Surgery
Vanderbilt University Medical Center
Section of Surgical Sciences
Nashville, Tennessee, USA
View the LimFlow Procedure
About LimFlow
When peripheral artery disease (PAD) progresses to Chronic Limb-Threatening Ischemia (CLTI), a patient’s options become limited. As the disease evolves to its late stages, patients may no longer be candidates for balloons or stents and may face bypass surgery, or worse, amputation.
However, they are ready to do anything to resolve the pain and regain quality of life.
Enter LimFlow.
In a minimally-invasive fashion, the LimFlow System is designed to bypass blocked arteries in the leg and rush blood back into the foot, potentially avoiding major amputation, resolving pain and promoting wound healing.